• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈病患者脑脊液中神经丝蛋白轻链亚基的定量分析

Quantification of the Light Subunit of Neurofilament Protein in Cerebrospinal Fluid of Huntington's Disease Patients.

作者信息

Szejko Natalia, Picón Carmen, García-Caldentey Juan, de Yebenes Justo Garcia, Alvarez-Cermeño Jose Carlos, Villar Luisa Maria, López-Sendón Moreno José Luis

机构信息

Department of Neurology, Medical University of Warsaw, Poland; Department of Bioethics, Medical University of Warsaw, Poland.

Servicio de Inmunología. Hospital Ramón y Cajal. Madrid. Spain.

出版信息

PLoS Curr. 2018 Aug 31;10:ecurrents.hd.280c8f9f7d9fa4f7f0c883d9f8e807da. doi: 10.1371/currents.hd.280c8f9f7d9fa4f7f0c883d9f8e807da.

DOI:10.1371/currents.hd.280c8f9f7d9fa4f7f0c883d9f8e807da
PMID:30258698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6128703/
Abstract

Neurofilament light proteins (NFL) are a structural element of the neuronal cytoskeleton and are released with neuronal damage. Its levels are increased in cerebrospinal fluid (CSF) in the setting of neurodegenerative diseases. We investigated the CSF-NFL levels of Huntington´s disease (HD) patients (participating in a clinical trial SAT-HD) as well as of premanifest carriers and compared their results with a sample of healthy controls and correlated CSF-NFL levels with demographic and clinical variables (baseline demographic characteristics and HD measures of disease severity). CSF levels were significantly higher in all HD subjects [5014.4 (1557.3) ng/l] and pre-manifest carriers [1050 (212.13) ng/l as compared to controls [331.4 (200.2) ng/l] (p<0.00) and were correlated with age (correlation coefficient -0.37, p<0.01) and CAG triplet number (0,51, p<0.05) in the subset of HD patients. NFL levels were not correlated with age in the control group. We did not find any correlation with the remaining variables. These results indicate, as in previous studies, that CSF-NFL levels are a marker of neuronal damage in HD. It seems to be a highly sensitive, but non-specific marker of axonal damage. One of the limitations of our study is a very small number of patients in pre-symptomatic group and lack of individuals with very advanced HD. Further investigations should focus on study of CSF-NFL levels in advanced patients, tracking prospectively CSF-NFL levels and analysing its correlation with the clinical course and usefulness to monitor disease progression, validation and quantification of NFL levels in more accessible biofluids.

摘要

神经丝轻链蛋白(NFL)是神经元细胞骨架的一种结构成分,在神经元受损时会被释放出来。在神经退行性疾病的情况下,其在脑脊液(CSF)中的水平会升高。我们研究了亨廷顿舞蹈病(HD)患者(参与临床试验SAT - HD)以及症状前携带者的脑脊液NFL水平,并将他们的结果与健康对照组样本进行比较,还将脑脊液NFL水平与人口统计学和临床变量(基线人口统计学特征以及HD疾病严重程度指标)进行关联分析。所有HD受试者的脑脊液水平[5014.4(1557.3)ng/l]和症状前携带者的脑脊液水平[1050(212.13)ng/l]均显著高于对照组[331.4(200.2)ng/l](p<0.00),并且在HD患者亚组中与年龄(相关系数 -0.37,p<0.01)和CAG三联体数目(0.51,p<0.05)相关。在对照组中,NFL水平与年龄无关。我们未发现其与其余变量存在任何关联。这些结果表明,与先前的研究一样,脑脊液NFL水平是HD中神经元损伤的一个标志物。它似乎是轴突损伤的一个高度敏感但非特异性的标志物。我们研究的局限性之一是症状前组患者数量非常少,并且缺乏HD晚期患者。进一步的研究应聚焦于晚期患者脑脊液NFL水平的研究,前瞻性地跟踪脑脊液NFL水平,并分析其与临床病程的相关性以及监测疾病进展、验证和量化更易获取生物流体中NFL水平的效用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aec/6128703/e2d29f888e1a/Figure-2-NFL.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aec/6128703/74f6c13cc454/Figure-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aec/6128703/e2d29f888e1a/Figure-2-NFL.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aec/6128703/74f6c13cc454/Figure-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aec/6128703/e2d29f888e1a/Figure-2-NFL.jpg

相似文献

1
Quantification of the Light Subunit of Neurofilament Protein in Cerebrospinal Fluid of Huntington's Disease Patients.亨廷顿舞蹈病患者脑脊液中神经丝蛋白轻链亚基的定量分析
PLoS Curr. 2018 Aug 31;10:ecurrents.hd.280c8f9f7d9fa4f7f0c883d9f8e807da. doi: 10.1371/currents.hd.280c8f9f7d9fa4f7f0c883d9f8e807da.
2
Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease.亨廷顿病患者脑脊液中神经丝三联蛋白轻链亚基水平
Parkinsonism Relat Disord. 2009 Mar;15(3):245-8. doi: 10.1016/j.parkreldis.2008.05.012. Epub 2008 Dec 4.
3
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.评估突变型亨廷顿蛋白和神经丝蛋白作为亨廷顿病潜在标志物的研究。
Sci Transl Med. 2018 Sep 12;10(458). doi: 10.1126/scitranslmed.aat7108.
4
NfL concentration in CSF is a quantitative marker of the rate of neurodegeneration in aging and Huntington's disease: a semi-mechanistic model-based analysis.脑脊液中神经丝轻链(NfL)浓度是衰老和亨廷顿舞蹈病中神经退行性变速率的定量标志物:基于半机制模型的分析
Front Neurosci. 2024 Jul 3;18:1420198. doi: 10.3389/fnins.2024.1420198. eCollection 2024.
5
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.血液中的神经丝轻链蛋白作为亨廷顿舞蹈病神经退行性变的潜在生物标志物:一项回顾性队列分析
Lancet Neurol. 2017 Aug;16(8):601-609. doi: 10.1016/S1474-4422(17)30124-2. Epub 2017 Jun 7.
6
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.脑脊液和血液中的神经丝轻蛋白与亨廷顿病 R6/2 小鼠的神经退行性变和疾病严重程度相关。
Sci Rep. 2017 Oct 26;7(1):14114. doi: 10.1038/s41598-017-14179-1.
7
Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?Tau蛋白还是神经丝轻链——哪种是更适合亨廷顿舞蹈症的生物标志物?
PLoS One. 2017 Feb 27;12(2):e0172762. doi: 10.1371/journal.pone.0172762. eCollection 2017.
8
Associations between prognostic index scores and plasma neurofilament light in Huntington's disease.亨廷顿病预后指数评分与血浆神经丝轻链的相关性。
Parkinsonism Relat Disord. 2022 Apr;97:25-28. doi: 10.1016/j.parkreldis.2022.02.023. Epub 2022 Mar 4.
9
Plasma neurofilament light in Huntington's disease: A marker for disease onset, but not symptom progression.亨廷顿病中的血浆神经丝轻链:疾病起始的标志物,但不是症状进展的标志物。
Parkinsonism Relat Disord. 2021 Jun;87:32-38. doi: 10.1016/j.parkreldis.2021.04.017. Epub 2021 Apr 28.
10
Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.多发性硬化症(MS)队列中的神经胶质和神经轴突生物标志物
Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:113-121.

引用本文的文献

1
Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic.反义寡核苷酸疗法:从设计到亨廷顿舞蹈病临床。
BioDrugs. 2022 Mar;36(2):105-119. doi: 10.1007/s40259-022-00519-9. Epub 2022 Mar 7.
2
Neurocytoskeleton Proteins in Cerebrospinal Fluid of People With HIV-1 Subtypes B and C.HIV-1 型 B 亚型和 C 亚型患者脑脊液中的神经细胞骨架蛋白。
J Acquir Immune Defic Syndr. 2020 Aug 15;84(5):514-521. doi: 10.1097/QAI.0000000000002389.

本文引用的文献

1
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.使用血清神经丝轻链蛋白监测多发性硬化症的疾病活动
Neurology. 2017 Nov 28;89(22):2230-2237. doi: 10.1212/WNL.0000000000004683. Epub 2017 Oct 27.
2
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.血液中的神经丝轻链蛋白作为亨廷顿舞蹈病神经退行性变的潜在生物标志物:一项回顾性队列分析
Lancet Neurol. 2017 Aug;16(8):601-609. doi: 10.1016/S1474-4422(17)30124-2. Epub 2017 Jun 7.
3
Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.
神经丝轻链蛋白作为神经元损伤的标志物:其在HIV-1感染中的应用及HIV阴性对照参考值综述
Expert Rev Mol Diagn. 2017 Aug;17(8):761-770. doi: 10.1080/14737159.2017.1341313. Epub 2017 Jun 14.
4
Alzheimer disease: Neurofilament light in the blood marks Alzheimer degeneration.阿尔茨海默病:血液中的神经丝轻链标志着阿尔茨海默病性退变。
Nat Rev Neurol. 2017 May;13(5):257. doi: 10.1038/nrneurol.2017.57. Epub 2017 Apr 18.
5
Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?Tau蛋白还是神经丝轻链——哪种是更适合亨廷顿舞蹈症的生物标志物?
PLoS One. 2017 Feb 27;12(2):e0172762. doi: 10.1371/journal.pone.0172762. eCollection 2017.
6
Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias.神经丝蛋白作为原发性进行性失语症诊断和监测的血液标志物。
Neurology. 2017 Mar 7;88(10):961-969. doi: 10.1212/WNL.0000000000003688. Epub 2017 Feb 8.
7
Plasma Cytokine Levels in Relation to Neuropsychiatric Symptoms and Cognitive Dysfunction in Huntington's disease.亨廷顿舞蹈症患者血浆细胞因子水平与神经精神症状及认知功能障碍的关系
J Huntingtons Dis. 2016 Dec 15;5(4):369-377. doi: 10.3233/JHD-160213.
8
Potential biomarkers to follow the progression and treatment response of Huntington's disease.用于追踪亨廷顿舞蹈症进展和治疗反应的潜在生物标志物。
J Exp Med. 2016 Nov 14;213(12):2655-2669. doi: 10.1084/jem.20160776. Epub 2016 Nov 7.
9
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.选定的脑脊液生物标志物表明亨廷顿病无早期神经炎症迹象。
Neurol Neuroimmunol Neuroinflamm. 2016 Sep 28;3(6):e287. doi: 10.1212/NXI.0000000000000287. eCollection 2016 Dec.
10
Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease.平衡核苷转运体ENT1作为亨廷顿病的生物标志物
Neurobiol Dis. 2016 Dec;96:47-53. doi: 10.1016/j.nbd.2016.08.013. Epub 2016 Aug 24.